ArticleVaccines2024

Development, Pre-Clinical Safety, and Immune Profile of RENOVAC-A Dimer RBD-Based Anti-Coronavirus Subunit Vaccine.

Muzaffar Muminov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.